OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30

$1.40−0.02 (-1.41%)

Close on Nov 12, 2026Market cap $73.47MP/E –Yield –

OKYO Pharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

OKYO Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?